NCT00000358已完成1 期
Safety Evaluation of Lofexidine for Treatment of Opioid Withdrawal
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 试验地点
- 2
研究概览
简要总结
The purpose of this study is to determine the safety of lofexidine in the treatment of opiate withdrawal. Preliminary data will also be obtained to assess the ability of lofexidine to alleviate opiate withdrawal signs and symptoms.
研究设计
- 研究类型
- Interventional
- 主要目的
- Treatment
入排标准
- 年龄范围
- 21 Years 至 59 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
研究点 (2)
Loading locations...
相似试验
已完成
1 期
Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 3Opioid-Related DisordersSubstance-Related DisordersNCT00000354National Institute on Drug Abuse (NIDA)
已完成
1 期
Evaluation of Lofexidine for Treatment of Opiate Withdrawal - 10Opioid-Related DisordersNCT00000345National Institute on Drug Abuse (NIDA)
已完成
3 期
Open-Label, Safety Study of LofexidineOpioid WithdrawalNCT02363998USWM, LLC (dba US WorldMeds)286
已完成
4 期
Lofexidine for Adults Undergoing Lumbar Spine SurgeryOpioid WithdrawalNCT04126083Mayo Clinic6
已完成
2 期
Lofexidine for Management of Opioid Withdrawal With XR-NTX TreatmentOpioid-use DisorderNCT04056182New York State Psychiatric Institute20